We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
An Immunological Perspective on the Mechanism of Drug Induced Liver Injury: Focused on Drugs for Treatment of Hepatocellular Carcinoma and Liver Transplantation.
- Authors
Lee, Soon Kyu; Choi, Jong Young; Jung, Eun Sun; Kwon, Jung Hyun; Jang, Jeong Won; Bae, Si Hyun; Yoon, Seung Kew
- Abstract
The liver is frequently exposed to potentially toxic materials, and it is the primary site of clearance of foreign agents, along with many innate and adaptive immune cells. Subsequently, drug induced liver injury (DILI), which is caused by medications, herbs, and dietary supplements, often occurs and has become an important issue in liver diseases. Reactive metabolites or drug–protein complexes induce DILI via the activation of various innate and adaptive immune cells. There has been a revolutionary development of treatment drugs for hepatocellular carcinoma (HCC) and liver transplantation (LT), including immune checkpoint inhibitors (ICIs), that show high efficacy in patients with advanced HCC. Along with the high efficacy of novel drugs, DILI has become a pivotal issue in the use of new drugs, including ICIs. This review demonstrates the immunological mechanism of DILI, including the innate and adaptive immune systems. Moreover, it aims to provide drug treatment targets, describe the mechanisms of DILI, and detail the management of DILI caused by drugs for HCC and LT.
- Subjects
DRUG side effects; HEPATOCELLULAR carcinoma; LIVER transplantation; LIVER injuries; IMMUNE checkpoint inhibitors
- Publication
International Journal of Molecular Sciences, 2023, Vol 24, Issue 5, p5002
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms24055002